Clinical Labs: Update on Status of NYS Lab Permit
August 27th, 2020
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
August 17th, 2020
Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
August 12th, 2020
Applied DNA Reports Fiscal Third Quarter 2020 Financial Results
August 6th, 2020
COVID-19 Diagnostic Kit Testing Capacity Increased by FDA EUA Amendment
July 31st, 2020
Applied DNA to Report Fiscal 2020 Third Quarter Financial Results After Market Close on August 6, 2020
July 30th, 2020
Applied DNA and Takis Report Positive Preclinical Results from LineaDNA™ Vaccine Candidates for COVID-19
July 17th, 2020
Applied DNA Appoints New Head of Investor Relations and Corporate Communications
July 15th, 2020
Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea™ COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment
July 9th, 2020
